potassium dichromate has been researched along with luteolin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asha, P; Dai, J; Divya, SP; Hitron, JA; Kim, D; Pratheeshkumar, P; Roy, RV; Shi, X; Son, YO; Wang, L; Wang, Y; Zhang, Z | 1 |
1 other study(ies) available for potassium dichromate and luteolin
Article | Year |
---|---|
Luteolin inhibits Cr(VI)-induced malignant cell transformation of human lung epithelial cells by targeting ROS mediated multiple cell signaling pathways.
Topics: Angiogenic Proteins; Animals; Anticarcinogenic Agents; Apoptosis Regulatory Proteins; Bronchi; Cell Line; Cell Survival; Cell Transformation, Neoplastic; Chromium; Cytoprotection; Dose-Response Relationship, Drug; Epithelial Cells; Free Radical Scavengers; Humans; Inflammation Mediators; Lung Neoplasms; Luteolin; Mice, Nude; Oxidative Stress; Potassium Dichromate; Reactive Oxygen Species; Signal Transduction; Transfection; Xenograft Model Antitumor Assays | 2014 |